Abiopharma

News list

Lynx1 Capital Management LP 🟢 acquired 520 shares of Korro Bio, Inc. (KRRO) at $10.60 Transaction Date: Mar 31, 2026 | Filing ID: 001845

Full text

News bot April 2, 2026, 4:01 p.m.
🔍 Lynx1 Capital Management LP (Executive)

Company: Korro Bio, Inc. (KRRO)

Report Date: 2026-03-31
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 520
Detailed Transactions and Holdings:
- Acquired 520 shares of Common stock, $0.001 par value per share at $10.6 per share (Direct)
  Date: 2026-03-31 | Code: P | equity_swap_involved: 0 | shares_owned_after: 1,538,296.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The securities to which this filing relates are held directly by Lynx1 Master Fund LP to which Lynx1 Capital Management LP (the "Investment Manager") serves as investment manager. Weston Nichols ("Mr. Nichols") is the sole member of Lynx1 Capital Management GP LLC, the general partner of the Investment Manager. Each of the Investment Manager and Mr. Nichols disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any.